CME Group

CME Group is a holding company. Through its subsidiaries, the company provides a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The company provides futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. The company also operates pcounterparty clearing provider CME Clearing. The company also provides optimization, reconciliation and processing services through TriOptima and Traiana.
  • TickerCME
  • ISINUS12572Q1058
  • ExchangeNASDAQ Stock Market
  • SectorFinancial Services
  • CountryUnited States

ValuEngine Rating and Forecast Report for CME

ValuEngine Rating and Forecast Report for CME

ValuEngine Rating and Forecast Report for CME

ValuEngine Rating and Forecast Report for CME

ValuEngine Rating and Forecast Report for CME

ValuEngine Rating and Forecast Report for CME

Valens Research

Valens Equity Insights and Inflections - 2020 05 05

IPG currently trades below historical averages relative to Uniform earnings, with a 13.0x Uniform P/E (Fwd V/E'). At these levels, the market is pricing in expectations for Uniform ROA to decline from 31% in 2019 to 20% by 2024, accompanied by 1% Uniform asset shrinkage going forward. Meanwhile, analysts have less bearish expectations, projecting Uniform ROA to only fade to 29% levels through 2021, accompanied by 7% Uniform asset shrinkage. That said, management is confident about their EBITA margin improvements and compelling product offerings. Current valuations appear to be pricing in overl...

Exchange Operators: US – Q1 2020 Update: Revenue and profit up as coronavirus crisis and oil price tensions drive exceptionally strong trading volumes

The US exchange operators reported exceptionally strong revenue and earnings in the first quarter, driven by increased trading volumes across all major product categories and regions.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of Consumer Cyclical names continue to reflect leadership. (ex. SBUX, RRGB, MCD, PZZA, and ROST.) • The Financial Sector has a number of attractive names developing major bases and staging RS reversals. (ex. SIVB, STT, AXP, SPGI, CME, GS, and JEF) • The Technology Sector has a number of technically attractive constituents. (ex. AMD, OLED, MPWR, CRUS, BR, FIS, VRSN, SAIC, LDOS, AAOI, BELFB, FARO, STX, and AAPL) .

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Energy Sector names continue to develop price and RS reversals. (ex. OXY, VAL, DO, RIG, SLB, MTDR, SM, MUR, WPX, XEC, JAG, TALO, APA, DVN, and EOG) • Aero-Defense related names are reversing price and RS downtrends. (ex. AVAV, NOC, AJRD, LMT, LHX, HII, and RTN.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Homebuilders and related stocks continue to indicate a bull market. (ex. BLD, MDC, MTH, MHO, IBP, PHM, CVCO, WLH, DHI, MAS, and GFF) • The Technology Sector continues to have a number of technically attractive names that are pulling back to support levels or remain in uptrends. (ex. SEDG, FORM, KLAC, TER, AMAT, AEIS, SYNA, OLED, QRVO, CRUS, FISV, EVTC, KN, JBL, CDW, and AAPL) • Insurance and Exchange related names remain leadership in the Financial Sector (ex. CME, ICE, CB, CINF, ALL, JRVR, and RNR)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Despite weakness in a number of Consumer Discretionary stocks, there are a number of names that remain attractive (ex. KBH, PHM, SIX, RRGB, WEN, SHAK, DNKN, and WMT) • The Consumer Staples Sector continues to have a number of leadership names. (ex. HSY, K, SAFM, VGR, and CHD) • Gold remains a leadership area of the market. (ex. RGLD, and NEM) • REITs and Utilities are increasingly moving as market leadership. (ex. OHI, WELL, LTC, DEA, IRT, EQR, UDR, ADC, EXR, CONE, NSA, AMT, NEE, IDA, DUK, and ES)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of Restaurant names are staging price and RS reversals or continue to have bullish formations. (ex. CHUY, JACK, CMG) • There are a few healthcare related names that continue to be bright spots and reflect leadership. (ex. CUTR, TFX, BSX, SYK, ADUS, CHE, COO, WST, TRHC, HUM, AMGN, PBH, MRK, and ZTS.) • REITs continue to show leadership characteristics' as many are hitting price and RS highs. (ex. OHI, SBRA, ESS, IRT, and MAA)

Valens Research

Valens Equity Insights and Inflections - 2020 05 05

IPG currently trades below historical averages relative to Uniform earnings, with a 13.0x Uniform P/E (Fwd V/E'). At these levels, the market is pricing in expectations for Uniform ROA to decline from 31% in 2019 to 20% by 2024, accompanied by 1% Uniform asset shrinkage going forward. Meanwhile, analysts have less bearish expectations, projecting Uniform ROA to only fade to 29% levels through 2021, accompanied by 7% Uniform asset shrinkage. That said, management is confident about their EBITA margin improvements and compelling product offerings. Current valuations appear to be pricing in overl...

Valens Research

CME - Embedded Expectations Analysis - 2020 04 28

 CME Group Inc. (CME:USA) currently trades above corporate average relative to UAFRS-based (Uniform) earnings, with a 33.3x Uniform P/E. At these levels, markets have bullish expectations for the firm, but management appears concerned about transaction growth, their NEX acquisition, and oil prices  Specifically, management may be concerned about the impact of uncleared margin rules on their clients, and they may be overstating the success of their NEX integration and synergy realization. In addition, they may lack confidence in their ability to sustain contract volume and interest rate swa...

Valens Research

Valens Equity Insights and Inflections - 2020 02 04

POST is currently trading near corporate averages relative to UAFRS-based (Uniform) Earnings, with a 21.8x Uniform P/E. At these levels, the market is pricing in expectations for Uniform ROA to decline from 20% in 2018 to 17% by 2023, accompanied by 8% Uniform Asset growth going forward. However, analysts have bullish expectations, projecting Uniform ROA to improve to 21% in 2020, accompanied by 2% Uniform Asset contraction. Meanwhile, management is confident about their market share growth and recent M&A activity. Current valuations appear to be pricing in overly bearish expectations for POST...

Valens Research

CME - Embedded Expectations Analysis - 2020 01 28

 CME Group Inc. (CME:USA) currently trades near historical highs relative to UAFRS-based (Uniform) Assets, with a 47.9x Uniform P/E. At these levels, markets have bullish expectations for the firm, but management appears concerned about new client growth, Federal Reserve activity, and their sales teams  Specifically, management may lack confidence in their ability to sustain volume growth and attract new clients and retail futures traders. Moreover, they may be exaggerating their innovation capacity, their ability to realize expense synergies, and the quality of their messaging policy. Furt...

MarketLine Department

Marrone Bio Innovations, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary Marketline's Marrone Bio Innovations, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Marrone Bio Innovations, Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its co...

Exchange Operators: US – Q1 2020 Update: Revenue and profit up as coronavirus crisis and oil price tensions drive exceptionally strong trading volumes

The US exchange operators reported exceptionally strong revenue and earnings in the first quarter, driven by increased trading volumes across all major product categories and regions.

Exchange Operators: US – Q4 2019 Update: Weaker trading volumes present revenue challenges, scale and diversification help maintain robust earnings and margins

US exchange operators continued to report robust earnings despite revenue challenges in the fourth quarter of 2019 because of the benefits of their scale and diversification

CME Group Inc.: Update to credit analysis

A detailed rationale for CME’s Aa3 stable rating, highlighting its consistently strong financial performance and conservative financial and strategic policies.

Exchange Operators: US - Q3 2019 Update: Higher trading volumes drive another quarter of strong results

US exchange operators continued to report robust results in the third quarter of 2019 because of the benefits of their scale and diversification

Moody's announces completion of a periodic review of ratings of CME Group Inc.

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of CME Group Inc.. Global Credit Research- 08 Oct 2019. New York, October 08, 2019-- Moody's Investors Service has completed a periodic review of the ratings of CME Group Inc. and other ratings that are associated with the same analytical unit.

ValuEngine Rating and Forecast Report for CME

ValuEngine Rating and Forecast Report for CME

ValuEngine Rating and Forecast Report for CME

ValuEngine Rating and Forecast Report for CME

ValuEngine Rating and Forecast Report for CME

ValuEngine Rating and Forecast Report for CME

ValuEngine Rating and Forecast Report for CME

ValuEngine Rating and Forecast Report for CME

ValuEngine Rating and Forecast Report for CME

ValuEngine Rating and Forecast Report for CME

ResearchPool Subscriptions

Get the most out of your insights

Get in touch